Multicenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma.
- DOI
- 10.1093/neuonc/noaf221
- Published
- 2026-02-01
- Container
- Neuro Oncol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/neuonc/noaf221,
title = {Multicenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma.},
author = {Omuro A and DeAngelis LM and Polley MC and Correa D and Wefel JS and Bovi JA and Rosenblum M and Corn BW and Aneja S and Grommes C and Peereboom DM and Lallana EC and Werner-Wasik M and Rogers CL and Iwamoto FM and Yu HM and Donnelly ED and Struve TD and Won M and Mehta MP.},
year = {2026},
journal = {Neuro Oncol},
doi = {10.1093/neuonc/noaf221},
url = {https://doi.org/10.1093/neuonc/noaf221}
}RIS
TY - JOUR TI - Multicenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma. AU - Omuro A AU - DeAngelis LM AU - Polley MC AU - Correa D AU - Wefel JS AU - Bovi JA AU - Rosenblum M AU - Corn BW AU - Aneja S AU - Grommes C AU - Peereboom DM AU - Lallana EC AU - Werner-Wasik M AU - Rogers CL AU - Iwamoto FM AU - Yu HM AU - Donnelly ED AU - Struve TD AU - Won M AU - Mehta MP. PY - 2026 JO - Neuro Oncol DO - 10.1093/neuonc/noaf221 UR - https://doi.org/10.1093/neuonc/noaf221 ER -
APA
A, O., LM, D., MC, P., D, C., JS, W., JA, B., M, R., BW, C., S, A., C, G., DM, P., EC, L., M, W., CL, R., FM, I., HM, Y., ED, D., TD, S., M, W., & MP., M. (2026). Multicenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma.. Neuro Oncol. https://doi.org/10.1093/neuonc/noaf221
Source records
- europe-pmc · retrieved 2026-09-26T17:33:03.614Z